Comparison of gene expression at the feto-maternal interface between normal and recurrent pregnancy loss patients

Reproduction, Fertility and Development

Volumn 14, Issue 3-4, 2002, Pages 235-240

  Baek, Kwang Hyun ^a   Choi, Bum Chae ^a   Lee, Jin Hie ^a   Choi, Hee Kyung ^a   Lee, Sook Hwan ^a   Kim, Jung Wook ^a   Hill, Joseph A ^a   Chung, Hyung Min ^a   Ko, Jung Jae ^a   Cha, Kwang Yul ^a  

^a CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CHORIONIC GONADOTROPIN; FIBRONECTIN; GELATINASE A; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MUCIN 1; PLACENTA PROTEIN 14; CA 15-3 ANTIGEN; GLOBIN; GLYCOPROTEIN; MESSENGER RNA; MUC1 MUCIN PEPTIDE; PAEP PROTEIN, HUMAN; PEPTIDE FRAGMENT; PLACENTA PROTEIN;

ANGIOGENESIS; ARTICLE; CHORION VILLUS SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; FEMALE; FETOPLACENTAL UNIT; GENE EXPRESSION; GENE ISOLATION; GENETIC PROCEDURES; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; NIDATION; NUCLEOTIDE SEQUENCE; PREGNANCY DISORDER; RECURRENT ABORTION; CHEMISTRY; CHORION VILLUS; GENETICS; IMMUNOLOGICAL TOLERANCE; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ABORTION, HABITUAL; CA-15-3 ANTIGEN; CHORIONIC GONADOTROPIN; CHORIONIC VILLI; EMBRYO IMPLANTATION; FEMALE; FIBRONECTINS; GENE EXPRESSION; GLOBINS; GLYCOPROTEINS; HUMANS; IMMUNE TOLERANCE; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEIC ACID HYBRIDIZATION; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036054461     PISSN: 10313613     EISSN: None     Source Type: Journal    
DOI: 10.1071/rd02008     Document Type: Article

References (22)

1. Identification of placental protein 14 as an immunosupressive factor in human reproduction
2. Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion
3. Prevalence of anti cardiolipin antibody in habitual aborters
4. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion
5. Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion
6. The measurement of CA-125 and placental protein 14 in uterine flushings in women with recurrent miscarriage; Relation to endometrial morphology
7. Endometrial protein PP14 and CA-125 in recurrent miscarriage patients; Correlation with pregnancy outcome
8. Suppression substractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries
9. Alterations in humoral immune responses associated with recurrent pregnancy loss
10. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways
11. Serum concentrations of human chorionic gonadotrophin and immunoreactive inhibin in early pregnancy and recurrent miscarriage: A longitudinal study
12. MUC1 in secretory phase endometrium: Expression in precisely dated biopsies and flushings from normal and recurrent miscarriage patients
13. Normal human ovary and ovarian tumors express glycodelin. A glycoprotein with immuno-suppressive and contraceptive properties
14. A novel X chromosome-linked genetic cause of recurrent spontaneous abortion
15. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death
16. Cytokines and immuno-endocrine factors in recurrent miscarriage
17. Identification of pachytene bivalents in human male meiosis using G-banding technique
18. Characterization and analysis of soluble suppressor factor from early human decidual cells
19. Cytotoxic effects of tumour necrosis factor (TNF)-α and interferon γ on cultured human trophoblast are modulated by fibronectin
20. Polycystic ovaries and recurrent miscarriage -a reappraisal
21. Hyperhomocysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss
22. Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle